相关实验视频

Updated: May 11, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

9.0K

FABP3甲基化作为一种新的生物标志物,用于区分和分类良性和恶性甲状腺结节

Haixia Huang1, Yifei Yin2, Yizhu Mao1

  • 1Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.

Frontiers in endocrinology
|September 29, 2025
PubMed
概括

甲状腺组织中FABP3基因甲基化的改变可以帮助区分良性和恶性甲状腺结节. 这一发现为甲状腺癌诊断和分类提供了潜在的新生物标志物.

关键词:
通过DNA甲基化.FABP3 FABP3是什么意思良性甲状腺结节是一种良性甲状腺结节.生物标志物生物标志物这是分类分类的分类.甲状腺癌是一种癌症.

更多相关视频

Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker13:26

Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker

Published on: March 31, 2018

10.3K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.1K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...